Who Paid My Doc
P4 Uncontrolled Gout FORWARD II
Research payments
$54,517,527
Through program year 2025, $54,517,527 in research payments was reported against P4 Uncontrolled Gout FORWARD II, across 138 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $249,947 | 7 |
| 2024 | Research | $54,267,581 | 131 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Amer Al-Khoudari Chandler, AZ Named on 4 payments
- Gilberto Seco Naranja, FL Named on 3 payments
- Jigar Shah Margate, FL Named on 2 payments
- Samy Metyas Covina, CA Named on 2 payments
- Amar Majjhoo Saint Clair Shores, MI Named on 2 payments
- Harold Bays Louisville, KY Named on 2 payments
- Swati Bharadwaj Mesa, AZ Named on 2 payments
- Alan Kivitz Duncansville, PA Named on 2 payments
- Dan La Tujunga, CA Named on 2 payments
- Eric Spivack Miami, FL Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.